Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer

Introduction: The aim of this study was to validate stage groupings in the eighth edition of the TNM classification in an independent Chinese cohort. Methods: We retrospectively analyzed a total of 3599 patients with pathological stage IA to IIIA (seventh edition of the TNM) NSCLC who underwent surgical treatment in two surgical centers in the People's Republic of China between 2005 and 2012. All patients were reclassified according to the eighth edition of the TNM classification. Survival was compared between adjacent stage groupings by using a log‐rank test and a Cox regression model. R2 was calculated to evaluate the discrimination of the two TNM stage classifications. Results: The median follow‐up time was 48.7 months. According to the eighth edition of the TNM classification, the overall survival (OS) of adjacent stage groupings showed significant differences except for IA3 vs. IB. The eighth edition of the TNM classification yielded a slightly higher R2 than the seventh edition (0.172 vs. 0.162). Conclusions: This study provided an external validation of the stage groupings in the eighth edition of the TNM classification for lung cancer among surgically treated Chinese patients with NSCLC.

[1]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[2]  Iaslc Staging,et al.  The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer , 2017 .

[3]  A. Nicholson,et al.  The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  F. Massera,et al.  Use of the Proposals of the International Association for the Study of Lung Cancer in the Forthcoming Edition of Lung Cancer Staging System to Predict Long-Term Prognosis of Operated Patients , 2010, Cancer journal.

[5]  Hisao Asamura,et al.  The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[7]  T. Chou,et al.  Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma. , 2016, The Annals of thoracic surgery.

[8]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  P. Goldstraw.  Staging manual in thoracic oncology , 2009 .

[10]  Kotaro Kameyama,et al.  Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. , 2009, The Journal of thoracic and cardiovascular surgery.

[11]  Sukki Cho,et al.  Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. , 2013, The Annals of thoracic surgery.

[12]  Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. , 2007, Journal of the National Cancer Institute.

[13]  Fergus Gleeson,et al.  The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  D. Addrizzo-Harris,et al.  Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[15]  G. Guyatt,et al.  Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .

[16]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.

[17]  K. Jöckel,et al.  Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE). , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  Jun Wang,et al.  Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer. , 2013, The Annals of thoracic surgery.

[20]  Hisao Asamura,et al.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Hua-Chuan Zheng,et al.  The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer , 2016, Oncotarget.

[23]  M Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  W. Tam,et al.  Novel therapeutic targets on the horizon for lung cancer. , 2016, The Lancet. Oncology.

[26]  J. Roth,et al.  Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. , 2009, The Journal of thoracic and cardiovascular surgery.

[27]  Qinghua Zhou,et al.  Comparisons between the National Comprehensive Cancer Network (NCCN) non‐small‐cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009 , 2010, Thoracic cancer.

[28]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  R. Schilsky,et al.  Adjuvant chemotherapy (AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. V. van Meerbeeck,et al.  Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments. , 2009, Lung cancer.

[31]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  Jeffrey Bradley,et al.  Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.